Nutlin | |
---|---|
(±)-4-[4,5-Bis(4-chlorophenyl)-2-(2-isopropoxy-4-methoxy-phenyl)-4,5-dihydro-imidazole-1-carbonyl]-piperazin-2-one Nutlin-3 |
|
Other names
Nutlin |
|
Identifiers | |
CAS number | 548472, (Nutlin-3) |
PubChem | 16755649 |
Jmol-3D images | Image 1 |
|
|
Properties | |
Molecular formula | C30H30Cl2N4O4 |
Molar mass | 581.4896 [g/mol] |
(verify) (what is: / ?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
Infobox references |
Nutlins are cis-imidazoline analogs which inhibit the interaction between mdm2 and tumour suppressor p53, and were discovered by screening a chemical library by Vassilev et al. Nutlin-1, Nutlin-2 and Nutlin-3 were all identified in the same screen,[1] however Nutlin-3 is the compound most commonly used in anti-cancer studies.[2]. Inhibiting the interaction between mdm2 and p53 stabilizes p53 and is thought to selectively induce a growth-inhibiting state called senescence in cancer cells. These compounds are therefore thought to work best on tumors that contain normal or wild type p53. Nutlin-3 has been shown to affect the production of p53 within minutes.[3]